有害事象報告詳細

VAERS ID	1269752
性別	女性
年齢
州コード	MA
製薬会社	ファイザー
ロット番号
ワクチン接種回数	1
接種日	2021-03-18
発生日	2021-03-25
状態	後遺症

症状

• 網膜静脈閉塞症(Retinal vein occlusion)

罹患中の病気

持病

Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None

その他医療

以前のワクチン接種

アレルギー

臨床検査

症状詳細

Retinal vein occlusion; This is a spontaneous report from a contactable consumer (patient) reported that a 24-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration, administered in arm left on 18Mar2021 13:00 as a single dose for covid-19 immunisation.
The patient was not pregnant at the time of vaccination.
The patient medical history was reported as none.
The patient had no known allergies.
The patient had no covid-19 prior vaccination.
The patient was not covid-19 tested post vaccination.
There were concomitant medications.
The patient received oral contraceptives in two weeks.
The patient had no other vaccines in four weeks.
On 25Mar2021, the patient experienced retinal vein occlusion.
The patient received Avastin injection as treatment for the event.
The event was resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage.
The outcome of the event was not recovered.
It was reported that the patient also received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported) via an unspecified route of administration, administered in arm left on 15Apr2021 as a single dose for covid-19 immunisation.
Information on the lot/batch number has been requested.